Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,782.81
(
2.51%
)
US TECH 100
24,204.40
(
2.81%
)
Dow Jones
47,909.92
(
2.85%
)
Brent Oil
94.84
(
-6.30%
)
Bitcoin
71,269.99
(
-1.00%
)
News Focus
News Focus
Post# of 257375
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122859
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ronpopeil post# 235604

Thursday, 11/12/2020 5:20:30 PM

Thursday, November 12, 2020 5:20:30 PM

Post# of 257375
Sumitovant Biopharma acquires UROV for_$16.25/sh_cash—a_96%_premium to today’s closing price:

https://www.prnewswire.com/news-releases/sumitovant-biopharma-and-urovant-sciences-announce-sumitovants-acquisition-of-remaining-stake-in-urovant-301172414.html

Sumitovant already owned a 72% equity stake in UROV. The nominal deal value (for the full company) is $681M.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today